<i>In vitro</i> release profile of rhTGF-β<sub>3</sub> from the EMLDS. Soon Sim Yang Long Hao Jin Sang-Hyug Park Moon Suk Kim Young Jick Kim Byung Hyune Choi Chun Tek Lee So Ra Park Byoung-Hyun Min 10.1371/journal.pone.0156292.g003 https://plos.figshare.com/articles/figure/_i_In_vitro_i_release_profile_of_rhTGF-_sub_3_sub_from_the_EMLDS_/3417523 <p>(A) Samples incubated in PBS were collected for 30 days and the amount of released rhTGF-β<sub>3</sub> was examined using ELISA. Approximately 86% of the total rhTGF-β<sub>3</sub> loaded was released from the EMLDS after 28 days. (B) The release rate of rhTGF-β<sub>3</sub> was approximately 8 ng/day for the first five days and approximately 4 ng/day thereafter. The release profiles did not significantly differ when the amount of rhTGF-β<sub>3</sub> loaded was varied from 50 ng to 200 ng.</p> 2016-06-03 11:55:05 rhTGF Articular Cartilage Repair Recombinant Successful cartilage repair novel drug delivery system vivo models ECM Sustained Releasing Growth Factor Delivery System drug delivery system MSC EMLDS